Survivors of Thyroid Cancer Remain Concerned About Quality of Life and Treatment Effects, Study Says
Free-Photos / Pixabay

Survivors of Thyroid Cancer Remain Concerned About Quality of Life and Treatment Effects, Study Says

According to a story from Medscape, a recent study is highlighting the fact that many thyroid cancer survivors are still worried about cancer-related problems years after the conclusion of treatment.…

Continue Reading Survivors of Thyroid Cancer Remain Concerned About Quality of Life and Treatment Effects, Study Says
Five Month Old Patient in the Spotlight for Primary Immunodeficiency Walk
stanvpetersen / Pixabay

Five Month Old Patient in the Spotlight for Primary Immunodeficiency Walk

According to a story from the Warwick Beacon, the first ever primary immunodeficiency (PI) awareness and fundraising walk in Rhode Island's history was held recently at Warwick City Park. The…

Continue Reading Five Month Old Patient in the Spotlight for Primary Immunodeficiency Walk
The Drug Stelara Gains Approval for Moderate to Severe Ulcerative Colitis in the EU
pixel2013 / Pixabay

The Drug Stelara Gains Approval for Moderate to Severe Ulcerative Colitis in the EU

According to a story from BioSpace, Janssen Pharmaceutical Companies recently announced that the European Commission (EC) has expanded the approved indication of the company's drug ustekinumab (marketed as Stelara). This…

Continue Reading The Drug Stelara Gains Approval for Moderate to Severe Ulcerative Colitis in the EU
Grant From The American Neuromuscular Foundation Will Focus on Chronic Inflammatory Demyelinating Polyneuropathy
mwooten / Pixabay

Grant From The American Neuromuscular Foundation Will Focus on Chronic Inflammatory Demyelinating Polyneuropathy

According to a story from newswise.com, the American Neuromuscular Foundation has recently awarded a grant to Dr. Karissa Gable. This grant will go towards a research project headed by Dr.…

Continue Reading Grant From The American Neuromuscular Foundation Will Focus on Chronic Inflammatory Demyelinating Polyneuropathy

This Company Just Announced Plans to Develop a Gene Therapy for Type 2A Charcot-Marie-Tooth Disease

According to a story from BioSpace, the genetic medicines company Passage Bio recently announced plans for its sixth program for gene therapy development. The company plans to work with the…

Continue Reading This Company Just Announced Plans to Develop a Gene Therapy for Type 2A Charcot-Marie-Tooth Disease
New Study Will Investigate Methods to Improve Cancer Trial Participation for Historically Under-Represented Groups
truthseeker08 / Pixabay

New Study Will Investigate Methods to Improve Cancer Trial Participation for Historically Under-Represented Groups

According to a story from journals.lww.com, The Lazarex Cancer Foundation and the University of California San Francisco have announced plans to work together on a three year study that will…

Continue Reading New Study Will Investigate Methods to Improve Cancer Trial Participation for Historically Under-Represented Groups

Patients in Mayo Clinic’s RIGHT Study Carried One or More Genetic Variants That May Affect Their Response to Medication

  Pharmacogenomics plays an important role in predicting whether patients will benefit from certain medications or if the medication will cause serious side effects. The process involves the way in…

Continue Reading Patients in Mayo Clinic’s RIGHT Study Carried One or More Genetic Variants That May Affect Their Response to Medication